All EDQM press releases
New EDQM document on recombinant viral vectored vaccines to support COVID19 vaccine developers
A broad range of technologies are being evaluated in the development of COVID-19 vaccines, from conventional approaches, such as live attenuated and inactivated vaccines, to more recent technologies, such as nucleic acid vaccines and recombinant viral vectored vaccines. Currently, limited...
Ten years at the service of consumer safety in Europe: over 600 analytical methods for cosmetics testing, 20 studies, 50 laboratories and more expected to join
The experts of the European Committee for Cosmetics and Consumer Health (CD-P-COS) held a virtual meeting on 22 and 23 June to define steps for advancing consumer protection in Europe and for reinforcing cross-border co-operation and independent cosmetics testing. The meeting also marked the...
Outcome of the 167th session of the European Pharmacopoeia Commission
The 167th session of the European Pharmacopoeia (Ph. Eur.) Commission on 23 June 2020 was the first ever to be held online, due to the COVID-19 pandemic.
EDQM provides COVID-19 vaccine developers with free access to quality standards applicable in Europe
The EDQM is committed to supporting vaccine developers during the coronavirus disease (COVID-19) pandemic – as well as contributing to the wider global effort to combat the virus – by openly sharing knowledge and offering temporary free access to relevant guidance and standards.
Annual OMCL Network meeting focuses on role of OMCLs during the COVID-19 pandemic - May 2020
The annual meeting of the European Network of Official Medicines Control Laboratories (OMCLs) took place from 12 to 15 May 2020, online and with a reduced programme due to the COVID-19 crisis. It was attended by more than 350 participants from 39 countries and was organised by the EDQM.
